Autologous tenocyte injections (ATI) are a relatively new, novel approach to treating recalcitrant tendon pathologies that have failed conservative management. An initial study published in 2013 by Wang et al defined this new procedure and found a significant improvement in all outcomes at 12months. The current paper discusses the results of a 4 year follow up of the same subjects and found that the successful outcomes were maintained.